Oral ATH434 improved motor function in monkeys
Alterity Therapeutics‘ ATH434 improved motor performance and overall function in non-human primates with induced Parkinson’s disease, according to…
Articles by Steve Bryson, PhD
Potential biomarkers seen in protein levels in amygdala region of brain
Altered levels of proteins in the amygdala, the brain region involved in memory, decision-making, and emotional responses, were discovered in…
FDA sets date in 2024 for decision on SPN-830 apomorphine pump
The U.S. Food and Drug Administration (FDA) has accepted Supernus Pharmaceuticals‘ new application seeking approval of its apomorphine infusion…
EvokAI’s MDM Flex Sensor earns CE mark in Europe for Parkinson’s
EvokAI Creative Labs’ Movement Disorder Monitor (MDM) Flex Sensor — which uses artificial intelligence (AI) in monitoring abnormal body…
Parkinson’s risk reflected in regional differences in air pollution: US study
Exposure to an air pollutant called fine particular matter (PM2.5) is significantly associated with an increased risk of developing…
Opal wearable sensor device found faster than standard tests in study
Opal, Clario’s wearable sensor device, was shown to detect early motor progression in people with Parkinson’s disease more…
PSAP protein may protect nerve cells in Parkinson’s, study shows
Levels of the protein prosaposin, known as PSAP, are altered in the brains of people with Parkinson’s disease, and…
Survey explores how patients balance treatment benefits, burdens
Adults with Parkinson’s disease are willing to take additional medicine to manage daily off times — when the benefits…
Newer diabetes medications may prevent Parkinson’s, study suggests
Newer glucose-lowering drugs used to treat type 2 diabetes, compared with a placebo, appear to lower a person’s risk of…
Impaired pupil reflex in Parkinson’s may contribute to vision problems
Pupil light reflex (PLR), the automatic contraction or dilation of the eye’s pupil in response to light levels, was found…